Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00228930 · ClinicalTrials.gov registry record
Tamoxifen Pharmacogenetics and Clinical Effects
A clinical trial, sponsored by National Institute of General Medical Sciences (NIGMS).
- Completed
- Registry status
- 297
- Enrollment target
NCT00228930 is a clinical trial that has completed, run by National Institute of General Medical Sciences (NIGMS). The registered enrollment target is 297 participants.
The verdict
NCT00228930 has completed, sponsored by National Institute of General Medical Sciences (NIGMS).
- COMPLETED
- Registry status
- 297 participants
- Enrollment target
Study Summary
The purpose of this research is to try to identify which women who take tamoxifen are likely to suffer from hot flashes or are more likely to have other side effects or benefits from the drug. The researchers will do so by determining whether there are mutations that normally occur in human DNA that might influence the way individuals respond to medications.
Interventions
- DRUG Tamoxifen (pharmacodynamic analysis)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2002-09 |
| Est. Completion | 2007-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00228930
The ClinicalTrials.gov registry entry for NCT00228930 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 297 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of General Medical Sciences (NIGMS), which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tamoxifen (pharmacodynamic analysis) is the first listed.
NCT00228930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00228930 about?
NCT00228930 is a clinical study titled "Tamoxifen Pharmacogenetics and Clinical Effects". The purpose of this research is to try to identify which women who take tamoxifen are likely to suffer from hot flashes or are more likely to have other side effects or benefits from the drug. The researchers will do so by determining whether there are mutations that normally occur in human DNA that...
What is the current status of trial NCT00228930?
This trial is currently completed. The enrollment target is 297 participants. The study started on 2002-09. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00228930?
The interventions under investigation include: Tamoxifen (pharmacodynamic analysis) (DRUG).
Who is sponsoring clinical trial NCT00228930?
This trial is sponsored by National Institute of General Medical Sciences (NIGMS), which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.